Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Outcomes in patients with ETV6 :: RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies

Katelyn Purvis, Yinmei Zhou, Seth E. Karol, Jeffrey E. Rubnitz, Raul C. Ribeiro, Shawn Lee, Jun J. Yang, W. Paul Bowman, Lu Wang, Stephanie B. Dixon, Kathryn G. Roberts, Qingsong Gao, Cheng Cheng, Charles G. Mullighan, Sima Jeha, Ching-Hon Pui, Hiroto Inaba

Blood (2025) 145 (2): 190–201.

https://doi.org/10.1182/blood.2024024936

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical Study on the Treatment of Poor Erythroid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation with Luspatercept

Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 2159.

https://doi.org/10.1182/blood-2024-206379

Published: 2024

Journal Articles

HMGB3 As a Cargo Protein for XPO1: Implications for Myelodysplastic Syndromes Prognosis and Treatment

Hongyan Tong, Wenli Yang, Liya Ma, Yudi Zhang, Wei Wang, Kongfei Li, Wei Lang, Lu Wang, Wenbin Yang, Hua Huang

Blood (2024) 144 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2024-206829

Published: 2024

Journal Articles

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2024-204843

Published: 2024

Journal Articles

ASXL1 Mutations in AML Are Associated with a Distinct Epigenetic State Which Highlights Vulnerabilities to Specific Epigenetic-Targeted Agents

Christopher Peter Mill, Warren C. Fiskus, Christine Birdwell, John A. Davis, Kaberi Das, Hanxi Hou, Surbhi Sharma, Koji Sasaki, Sanam Loghavi, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Lu Wang, Kapil N. Bhalla

Blood (2024) 144 (Supplement 1): 1349.

https://doi.org/10.1182/blood-2024-204117

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Journal Articles

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Qiuyu Guo, Ye-Jun Wu, Gao-Chao Zhang, Yu-Xiu Chen, Meng-Lin Li, Meng-Yu Xiao, Jian-Ying Zhou, Lu-Lu Wang, Meng-Tong Zang, Zhuo-Yu An, Hai-Xia Fu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2024) 144 (Supplement 1): 425.

https://doi.org/10.1182/blood-2024-203555

Published: 2024

Journal Articles

Oncogenic Potential and Sensitivity to Menin Inhibitors of a Novel Fusion KAT6B::NUTM2B in Congenital Myeloid Sarcoma with Bone Marrow Involvement

Rebecca Voss, Wenqing Qi, Yen-Chun Liu, Jing Ma, La'Ron Browne, Mahsa Khanlari, Juan M Barajas, Melvin Thomas, III, Victor B Pastor Loyola, Hui Cao, Seth E. Karol, Jeffrey E. Rubnitz, Jeffery M Klco, Lu Wang

Blood (2024) 144 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2024-208358

Published: 2024

Journal Articles

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Lu Zhao, Yuqing Liu, Ting Chen, Yimei Feng, Han Yao, Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Shuhan Tang, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2024) 144 (Supplement 1): 7192.

https://doi.org/10.1182/blood-2024-205161

Published: 2024

Journal Articles

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Han Yao, Xiaoqi Wang, Ruihao Huang, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2024-206679

Published: 2024

Journal Articles

Loss of the Interaction Linking the αIIb Thigh Domain K514 to the β3 I-EGF2 Domain E500 Results in Constitutive Fibrinogen Binding to αIIbβ3

Lu Wang, Jihong Li, Barry S. Coller

Blood (2024) 144 (Supplement 1): 5416.

https://doi.org/10.1182/blood-2024-205370

Published: 2024

Journal Articles

Lessons Learned from Mapping the Process of De-Implementation of Routine Cytogenetics in the Diagnosis of Pediatric Acute Lymphoblastic Leukemia

Marta Salek, Kenneth Busby, III, Nathaniel Webb, Dylan Graetz, Charles G. Mullighan, Thomas B. Alexander, Nickhill Bhakta, Megan C Roberts, Lu Wang

Blood (2024) 144 (Supplement 1): 7599.

https://doi.org/10.1182/blood-2024-211054

Published: 2024

Journal Articles

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Lidan Zhu, Jia Liu, Huanfeng Liu, Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Ting Chen, Yimei Feng, Yuqing Liu, Han Yao, Lu Zhao, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7317.

https://doi.org/10.1182/blood-2024-207037

Published: 2024

Journal Articles

Which Patients Will Benefit More?–the Impact of Different Biological Characteristics of High-Risk Acute Myeloid Leukemia on the Efficacy of Maintenance Treatment with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation

Jia Liu, Lidan Zhu, Huanfeng Liu, Shichun Gao, Lu Wang, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 7435.

https://doi.org/10.1182/blood-2024-207733

Published: 2024

Journal Articles

Case Report: Diagnosis and Management of Myeloid/Lymphoid Neoplasms with ETV6::FLT3 Rearrangement

Victor B Pastor Loyola, Yen-Chun Liu, Patrick R. Blackburn, Jennifer L. Neary, Larissa B. Furtado, Lu Wang, Mary Elizabeth Elizabeth Ross, Raul C. Ribeiro, Mohammad K. Eldomery

Blood (2024) 144 (Supplement 1): 6679.

https://doi.org/10.1182/blood-2024-211509

Published: 2024

Journal Articles

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Lu Wang, Jia Liu, Lidan Zhu, Huanfeng Liu, Shichun Gao, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 6176.

https://doi.org/10.1182/blood-2024-205435

Published: 2024

Journal Articles

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

Hui Zeng, Suqi Deng, Juan Du, Huien Zhan, Kexiu Huang, Xue Zheng, Ying Xu, Lu Wang

Blood (2023) 142 (Supplement 1): 1592.

https://doi.org/10.1182/blood-2023-189148

Published: 2023

Journal Articles

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Huanfeng Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lu Wang, Peiyan Kong, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6967.

https://doi.org/10.1182/blood-2023-188407

Published: 2023

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Blood (2023) 142 (Supplement 1): 5384.

https://doi.org/10.1182/blood-2023-184470

Published: 2023

NARROW

Outcomes in patients with ETV6 :: RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies

Clinical Study on the Treatment of Poor Erythroid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation with Luspatercept

HMGB3 As a Cargo Protein for XPO1: Implications for Myelodysplastic Syndromes Prognosis and Treatment

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

ASXL1 Mutations in AML Are Associated with a Distinct Epigenetic State Which Highlights Vulnerabilities to Specific Epigenetic-Targeted Agents

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Oncogenic Potential and Sensitivity to Menin Inhibitors of a Novel Fusion KAT6B::NUTM2B in Congenital Myeloid Sarcoma with Bone Marrow Involvement

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Loss of the Interaction Linking the αIIb Thigh Domain K514 to the β3 I-EGF2 Domain E500 Results in Constitutive Fibrinogen Binding to αIIbβ3

Lessons Learned from Mapping the Process of De-Implementation of Routine Cytogenetics in the Diagnosis of Pediatric Acute Lymphoblastic Leukemia

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Which Patients Will Benefit More?–the Impact of Different Biological Characteristics of High-Risk Acute Myeloid Leukemia on the Efficacy of Maintenance Treatment with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation

Case Report: Diagnosis and Management of Myeloid/Lymphoid Neoplasms with ETV6::FLT3 Rearrangement

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only